Review Article | Open Access
Volume 2022 |Article ID 9898241 | https://doi.org/10.34133/2022/9898241

An Overview of Antiviral Peptides and Rational Biodesign Considerations

Ying-Chiang J. Lee iD ,1 Jaden D. Shirkey,1 Jongbeom Park,1 Karishma Bisht,1 and Alexis J. Cowan1

Department of Molecular Biology, Princeton University, Princeton, New Jersey 08544, USA

Received 
17 Jan 2022
Accepted 
04 Apr 2022
Published
17 May 2022

Abstract

Viral diseases have contributed significantly to worldwide morbidity and mortality throughout history. Despite the existence of therapeutic treatments for many viral infections, antiviral resistance and the threat posed by novel viruses highlight the need for an increased number of effective therapeutics. In addition to small molecule drugs and biologics, antimicrobial peptides (AMPs) represent an emerging class of potential antiviral therapeutics. While AMPs have traditionally been regarded in the context of their antibacterial activities, many AMPs are now known to be antiviral. These antiviral peptides (AVPs) have been shown to target and perturb viral membrane envelopes and inhibit various stages of the viral life cycle, from preattachment inhibition through viral release from infected host cells. Rational design of AMPs has also proven effective in identifying highly active and specific peptides and can aid in the discovery of lead peptides with high therapeutic selectivity. In this review, we highlight AVPs with strong antiviral activity largely curated from a publicly available AMP database. We then compile the sequences present in our AVP database to generate structural predictions of generic AVP motifs. Finally, we cover the rational design approaches available for AVPs taking into account approaches currently used for the rational design of AMPs.

Contact us

Lucy Wang, info@biodesignresearch.com, +86 177 0518 5080
5 Tongwei Road, Xuanwu District, Nanjing, Jiangsu Province, China

© 2019-2023 BioDesign Research. All rights Reserved.  ISSN 2693-1257.

Back to top